Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Receivables - Other: 2023

Historic Receivables - Other for Ptc Therapeutics (PTCT) over the last 1 years, with Dec 2023 value amounting to $200,000.

  • Ptc Therapeutics' Receivables - Other was N/A to $800,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $800,000, marking a year-over-year change of. This contributed to the annual value of $200,000 for FY2023, which is N/A change from last year.
  • As of FY2023, Ptc Therapeutics' Receivables - Other stood at $200,000.
  • In the past 5 years, Ptc Therapeutics' Receivables - Other ranged from a high of $200,000 in FY2023 and a low of $200,000 during FY2023.
  • Over the past 1 years, Ptc Therapeutics' median Receivables - Other value was $200,000 (recorded in 2023), while the average stood at $200,000.